The short version of animal models fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-22 and is reviewed periodically as new material appears.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are established using reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and yields a percentage purity. Mass spectrometry, typically with electrospray ionization, confirms the molecular mass against the expected value. Amino acid analysis or peptide mapping provides additional sequence confirmation. These methods are complementary, since chromatography measures how much material is present while mass spectrometry verifies what that material is. A certificate of analysis normally reports both.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
== SE == se – (s) Northern Sami language (ISO 639-1 code) Se – (s) Selenium SE (s) Seychelles (FIPS 10-4 country code) (i) Societas Europaea (form of business organization in the EU) South-east (s) Sweden (ISO 3166 digram) (i) Synthetic Environment Systems engineering SEAD – (i) Suppression of Enemy Air Defence(s) SEADI – (i) Senior Executioner of Approved Driving Instructors SEAFDEC – (p) Southeast Asian Fisheries Development Center SEAL – (p) SEa-Air-Land SEAT – (a) Sociedad Española de Automóviles de Turismo (Spanish for "Spanish Touring Car Company") SEATO – (a) Southeast Asia Treaty Organization SeaWiFS – (p) Sea-Viewing Wide Field of View Sensor (satellite instrument) SEC (i) U.S. Securities and Exchange Commission (p) Security Southeastern Conference SECaaS - (p) Security-as-a-Service SECAM – (a) Séquentiel couleur à mémoire (French for "Colour Sequential with Memory"; TV standard, cf. NTSC, PAL) SECDEF – (p) (U.S.) Secretary of Defense SED – (i) CERDEC Software Engineering Directorate SEDRIS – (a) Synthetic Environment Data Representation and Interchange Specification SEE – (a) Small Emplacement Excavator SEG – (i) Society of Exploration Geophysicists SEG – (i) Special Escort Group SEK – (s) Swedish krona (ISO 4217 currency code) Selkent – (p) South East London & Kent Bus Company SELT – (a) Single Ended Line Test (ing) SEM (i/a) Sensor Employment Manager Switch to Email Mode, i.e.
== Climate change == Climate change exacerbates threats to aquatic plants through rising temperatures, altered precipitation patterns, and increased frequency of extreme weather events. Warmer temperatures can favor invasive species that outcompete native plants. For example, studies predict that the ranges of invasive species like Egeria densa and Myriophyllum aquaticum may expand significantly by 2070 due to climate change. Additionally, earlier spring warming allows invasive species to establish before native plants, giving them a competitive advantage. Climate-induced changes also affect water levels and flow regimes, impacting aquatic plant distribution and health. Droughts can reduce water availability, while intense storms can lead to increased runoff and sedimentation, both detrimental to aquatic vegetation.
biometal Any metallic element found naturally in small but measurable amounts in biological contexts. Metal ions play important roles in many biochemical processes and some are essential for normal function in living organisms, especially iron (Fe), zinc (Zn), copper (Cu), manganese (Mn), magnesium (Mg), potassium (K), sodium (Na), and calcium (Ca).
Sources: en.wikipedia.org
In the case of air pumps, diaphragm pumps are considered to be a type of pump that utilizes positive displacement. A simple diaphragm pump contains a chamber that acts like a springy diaphragm. When compressed, the air within the diaphragm gets expelled. When the diaphragm is decompressed, the chamber refills with air. A simple example for a diaphragm pump is a foot pump that requires the user to constantly step up and down on the pump to inflate something. Engine-driven tire pump Several companies developed engine-driven tire pumps in the brass era of the automobile. Reciprocating Pumps
=== Pharmacodynamics === Benorterone is an antiandrogen, or an antagonist of the androgen receptor (AR), the biological target of the androgen sex hormones testosterone and dihydrotestosterone. In one study, the affinity of benorterone for the AR was found to be about 5-fold greater than that of cyproterone acetate in rat prostate cytosol; the Ki values were 0.7 nM for benorterone and 3.7 nM for cyproterone acetate, which were 243% and 46% of those of testosterone (Ki = 1.7 nM), respectively. However, another study found that benorterone had only 11% of the affinity of dihydrotestosterone for the androgen receptor. Although an antiandrogen, benorterone actually is a very weak partial agonist of the AR and has been reported to possess weak androgenic activity. The same is true for cyproterone acetate and other steroidal antiandrogens. Unlike certain other steroidal antiandrogens such as cyproterone acetate, benorterone is not also a progestogen, instead being described as a selective and pure AR antagonist similarly to nonsteroidal antiandrogens such as flutamide and bicalutamide. However, although it is described as not being a progestogen, benorterone was found to produce "a highly variable decrease in plasma testosterone levels," indicating that it has weak antigonadotropic effects. The reasons for this are unclear, as other pure antiandrogens such as cyproterone (not cyproterone acetate) and flutamide do not do this and instead produce consistent increases in testosterone levels.
=== Iraq and Saddam Hussein === Writing for The Observer in April 2003, David Aaronovitch speculated that Galloway's support for Ba'athist Iraq and Saddam Hussein may have been based on "the belief that my enemy's enemy is my friend. Or, in the context of the modern world, any anti-American will do. When Iraq stopped being a friend of the West it became a friend of George's." According to Tam Dalyell, Galloway had been the "only one MP that I can recollect making speeches about human rights in Iraq" in the House of Commons. Galloway opposed the 1991 Gulf War and was critical of the effect that the subsequent sanctions had on the people of Iraq.
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.